{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10447148", "DateCompleted": {"Year": "1999", "Month": "10", "Day": "29"}, "DateRevised": {"Year": "2017", "Month": "11", "Day": "16"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0891-9887", "JournalIssue": {"Volume": "12", "Issue": "1", "PubDate": {"Year": "1999", "Season": "Spring"}}, "Title": "Journal of geriatric psychiatry and neurology", "ISOAbbreviation": "J Geriatr Psychiatry Neurol"}, "ArticleTitle": "St. John's wort and antidepressant drug interactions in the elderly.", "Pagination": {"StartPage": "7", "EndPage": "10", "MedlinePgn": "7-10"}, "Abstract": {"AbstractText": ["There is increasing interest in and use of the herbal preparation St. John's wort. Hypericin, the major active ingredient, has many psychoactive properties. The agent is sold in the US as a nutritional supplement and is recommended for numerous conditions, including depression, anxiety, insomnia, and inflammation. We report a series of five cases of clinically diagnosed central serotonergic syndrome among elderly patients who combined prescription antidepressants with St. John's wort. Older adults are large consumers of both over-the-counter and prescription medications. They are particularly vulnerable to interactions between medications and products sold as nutritional or herbal supplements. St. John's wort requires further evaluation due to potential for drug interactions with central nervous system agents and for more definitive therapeutic indications."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychiatry, The Jewish Home and Hospital, New York, New York 10025-3757, USA."}], "Identifier": [], "LastName": "Lantz", "ForeName": "M S", "Initials": "MS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Buchalter", "ForeName": "E", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Giambanco", "ForeName": "V", "Initials": "V"}], "PublicationTypeList": ["Case Reports", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Geriatr Psychiatry Neurol", "NlmUniqueID": "8805645", "ISSNLinking": "0891-9887"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Aged, 80 and over"}, {"QualifierName": ["metabolism", "therapeutic use"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Depressive Disorder"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": ["adverse effects", "chemistry"], "DescriptorName": "Ericales"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Herb-Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["adverse effects", "chemistry"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "8", "Day": "14"}, {"Year": "1999", "Month": "8", "Day": "14", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "8", "Day": "14", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10447148", "10.1177/089198879901200103"]}}], "PubmedBookArticle": []}